GMED Globus Medical Inc

  1. Stocks
  2. Healthcare
  3. NYSE: GMED

Price (delayed)

$52.65

Market cap

$5.28B

P/E Ratio

27.86

Dividend/share

N/A

EPS

$1.89

Enterprise value

$5.13B

Based in Audubon, Pennsylvania, Globus Medical, Inc. was founded in 2003 by an experienced team of professionals with a shared vision to create products that enable surgeons to promote healing ...

Highlights
The P/E is 33% less than the last 4 quarters average of 41.8 and 31% less than the 5-year quarterly average of 41.0
The EPS has grown by 28% year-on-year and by 23% since the previous quarter
GMED's quick ratio is down by 4.6% year-on-year
Sector: Healthcare
Industry: Medical Devices
Website: http://www.globusmedical.com
Peers: NUVA SYK OFIX ATEC

Key stats

What are the main financial stats of GMED
Market
Shares outstanding
100.3M
Market cap
$5.28B
Enterprise value
$5.13B
Valuations
Price to earnings (P/E)
27.86
Price to book (P/B)
2.85
Price to sales (P/S)
5.17
EV/EBIT
22.42
EV/EBITDA
17.27
EV/Sales
5.02
Earnings
Revenue
$1.02B
EBIT
$228.79M
EBITDA
$297.04M
Free cash flow
$104.42M
Per share
EPS
$1.89
Free cash flow per share
$1.04
Book value per share
$18.49
Revenue per share
$10.18
TBVPS
$18.07
Balance sheet
Total assets
$2.08B
Total liabilities
$229.75M
Debt
$0
Equity
$1.85B
Working capital
$824.14M
Liquidity
Debt to equity
0
Current ratio
6.18
Quick ratio
4.14
Net debt/EBITDA
-0.51
Margins
EBITDA margin
29%
Gross margin
74.2%
Net margin
18.6%
Operating margin
22.3%
Efficiency
Return on assets
9.5%
Return on equity
10.7%
Return on invested capital
16%
Return on capital employed
11.9%
Return on sales
22.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

GMED stock price

How has the Globus Medical stock price performed over time
Intraday
-1%
1 week
0.27%
1 month
-11.41%
1 year
-23.81%
YTD
-29.11%
QTD
-29.11%

Financial performance

How have Globus Medical's revenue and profit performed over time
Revenue
$1.02B
Gross profit
$759.12M
Operating income
$227.95M
Net income
$190.17M
Gross margin
74.2%
Net margin
18.6%
The operating income has increased by 33% YoY and by 19% QoQ
The company's net income rose by 27% YoY and by 23% QoQ
The company's operating margin rose by 25% YoY and by 16% QoQ
The net margin has increased by 20% since the previous quarter and by 19% year-on-year

Growth

What is Globus Medical's growth rate over time

Valuation

What is Globus Medical stock price valuation
P/E
27.86
P/B
2.85
P/S
5.17
EV/EBIT
22.42
EV/EBITDA
17.27
EV/Sales
5.02
The P/E is 33% less than the last 4 quarters average of 41.8 and 31% less than the 5-year quarterly average of 41.0
The EPS has grown by 28% year-on-year and by 23% since the previous quarter
The stock's P/B is 28% less than its 5-year quarterly average of 4.0 and 22% less than its last 4 quarters average of 3.7
GMED's equity is up by 6% year-on-year and by 4.7% since the previous quarter
GMED's P/S is 25% lower than its 5-year quarterly average of 7.0 and 22% lower than its last 4 quarters average of 6.7
Globus Medical's revenue has increased by 7% YoY and by 2.5% QoQ

Efficiency

How efficient is Globus Medical business performance
The return on sales has grown by 25% year-on-year and by 18% since the previous quarter
The ROA is up by 20% since the previous quarter and by 19% year-on-year
Globus Medical's return on equity has increased by 20% QoQ and by 19% YoY
GMED's ROIC is up by 18% since the previous quarter and by 16% year-on-year

Dividends

What is GMED's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GMED.

Financial health

How did Globus Medical financials performed over time
The company's total liabilities rose by 8% QoQ and by 6% YoY
GMED's total assets is up by 6% year-on-year and by 5% since the previous quarter
The debt is 100% smaller than the equity
GMED's equity is up by 6% year-on-year and by 4.7% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.